K Dolan

Summary

Affiliation: University of New South Wales
Country: Australia

Publications

  1. doi request reprint Characteristics of Iranian women seeking drug treatment
    Kate Dolan
    Program of International Research and Training, National Drug and Research Centre, University of New South Wales, Sydney 2052, Australia
    J Womens Health (Larchmt) 20:1687-91. 2011
  2. pmc Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort
    Suzy Teutsch
    School of Medical Sciences, The University of New South Wales, Sydney, New South Wales, Australia
    BMC Public Health 10:633. 2010
  3. ncbi request reprint Can drug injectors be encouraged to adopt non-injecting routes of administration (NIROA) for drugs?
    Kate Dolan
    National Drug and Alcohol Research Centre, UNSW, Sydney, Australia
    Drug Alcohol Rev 23:281-6. 2004
  4. ncbi request reprint HIV in prison in low-income and middle-income countries
    Kate Dolan
    Program of International Research and Training, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Lancet Infect Dis 7:32-41. 2007
  5. ncbi request reprint Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection
    Kate A Dolan
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Addiction 100:820-8. 2005
  6. ncbi request reprint A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system
    Kate A Dolan
    National Drug and Alcohol Research Centre, UNSW, Sydney NSW 2052, Australia
    Drug Alcohol Depend 72:59-65. 2003
  7. pmc HIV in Indian prisons: risk behaviour, prevalence, prevention & treatment
    Kate Dolan
    Program of International Research and Training, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Indian J Med Res 132:696-700. 2010
  8. doi request reprint The establishment of a methadone treatment clinic for women in Tehran, Iran
    Kate Dolan
    Program of International Research and Training, National Drug and Alcohol Research Centre, University of NSW, Sydney 2052, Australia
    J Public Health Policy 32:219-30. 2011
  9. ncbi request reprint Prison-based syringe exchange programmes: a review of international research and development
    Kate Dolan
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Addiction 98:153-8. 2003
  10. ncbi request reprint Surveillance and prevention of hepatitis C in Australian prisons
    K Dolan
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia
    Can HIV AIDS Policy Law Newsl 5:68-9. 2000

Collaborators

Detail Information

Publications39

  1. doi request reprint Characteristics of Iranian women seeking drug treatment
    Kate Dolan
    Program of International Research and Training, National Drug and Research Centre, University of New South Wales, Sydney 2052, Australia
    J Womens Health (Larchmt) 20:1687-91. 2011
    ..Urine and blood samples were collected and tested for morphine, HIV, hepatitis C virus (HCV), and sexually transmitted infections (STIs)...
  2. pmc Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort
    Suzy Teutsch
    School of Medical Sciences, The University of New South Wales, Sydney, New South Wales, Australia
    BMC Public Health 10:633. 2010
    ..Previous studies of HCV incidence have been based on small case numbers and have not distinguished risk events in prison from those in the community...
  3. ncbi request reprint Can drug injectors be encouraged to adopt non-injecting routes of administration (NIROA) for drugs?
    Kate Dolan
    National Drug and Alcohol Research Centre, UNSW, Sydney, Australia
    Drug Alcohol Rev 23:281-6. 2004
    ....
  4. ncbi request reprint HIV in prison in low-income and middle-income countries
    Kate Dolan
    Program of International Research and Training, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Lancet Infect Dis 7:32-41. 2007
    ..Systematic collection of data to inform HIV prevention strategies in prison is urgently needed. The introduction and evaluation of HIV prevention strategies in prisons are warranted...
  5. ncbi request reprint Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection
    Kate A Dolan
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Addiction 100:820-8. 2005
    ..To examine the long-term impact of methadone maintenance treatment (MMT) on mortality, re-incarceration and hepatitis C seroconversion in imprisoned male heroin users...
  6. ncbi request reprint A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system
    Kate A Dolan
    National Drug and Alcohol Research Centre, UNSW, Sydney NSW 2052, Australia
    Drug Alcohol Depend 72:59-65. 2003
    ..The aim was to determine whether methadone maintenance treatment reduced heroin use, syringe sharing and HIV or hepatitis C incidence among prisoners...
  7. pmc HIV in Indian prisons: risk behaviour, prevalence, prevention & treatment
    Kate Dolan
    Program of International Research and Training, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Indian J Med Res 132:696-700. 2010
    ..HIV is a major health challenge for prison authorities. HIV in prisons has implications for HIV in the general community. The aim of this paper was to gather information on HIV risk, prevalence, prevention and treatment in prisons in India...
  8. doi request reprint The establishment of a methadone treatment clinic for women in Tehran, Iran
    Kate Dolan
    Program of International Research and Training, National Drug and Alcohol Research Centre, University of NSW, Sydney 2052, Australia
    J Public Health Policy 32:219-30. 2011
    ..We conclude that female drug users will make use of harm reduction services if they are provided in a setting designed and operated for women...
  9. ncbi request reprint Prison-based syringe exchange programmes: a review of international research and development
    Kate Dolan
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Addiction 98:153-8. 2003
    ..Overall, this review indicated that prison syringe exchange programmes are feasible and do provide benefit in the reduction of risk behaviour and the transmission of blood-borne infection without any unintended negative consequences...
  10. ncbi request reprint Surveillance and prevention of hepatitis C in Australian prisons
    K Dolan
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW 2052, Australia
    Can HIV AIDS Policy Law Newsl 5:68-9. 2000
    ..In Australia, an action plan for the surveillance and prevention of HCV in prisons has been developed as a result of meetings held in 1998 and 1999. We reproduce here the executive summary of the plan...
  11. ncbi request reprint An overview of the use of urine, hair, sweat and saliva to detect drug use
    Kate Dolan
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Drug Alcohol Rev 23:213-7. 2004
    ..The analysis of sweat may be useful for continuous monitoring of drug use (1-14 days). Drug testing has become a fast, convenient process with the development of point-of-collection drug testing devices...
  12. doi request reprint Incidence and risk for acute hepatitis C infection during imprisonment in Australia
    Kate Dolan
    National Drug and Alcohol Research Centre, Univeristy of New South Wales, Sydney, NSW, 2052, Australia
    Eur J Epidemiol 25:143-8. 2010
    ..Prison inmates were at high risk of HCV infection, despite some reduction in high-risk behaviours and access to prevention services. To prevent HCV transmission in prisons, better prevention strategies are required...
  13. ncbi request reprint Value for money in drug treatment: economic evaluation of prison methadone
    Emma Warren
    Centre for Health Economics Research and Evaluation, CHERE, University of Technology, Sydney, Australia
    Drug Alcohol Depend 84:160-6. 2006
    ..One reason for this is the complexity of undertaking evaluations in the prison setting. This paper estimates the cost-effectiveness of the New South Wales (NSW) prison methadone program...
  14. doi request reprint Presence of hepatitis C virus in syringes confiscated in prisons in Australia
    Kate Dolan
    National Drug and Alcohol Research Center, University of New South Wales, Sydney, NSW 2052, Australia
    J Gastroenterol Hepatol 24:1655-7. 2009
    ..Needlestick injuries are an occupational hazard for prison officers. This study aimed to assess the presence of hepatitis C virus (HCV) in syringes found in prisons...
  15. ncbi request reprint A review of HIV in prisons in Nepal
    K Dolan
    Program of International Research and Training, National Drug and Alcohol Research Centre, University of New South Wales, Australia
    Kathmandu Univ Med J (KUMJ) 7:351-4. 2009
    ..HIV in prisons is a serious public health concern. People in prison are at risk of contracting HIV through injecting drug use, unprotected sex and tattooing. However, most countries have largely neglected HIV prevention and care in prisons...
  16. ncbi request reprint A mathematical model of HIV transmission in NSW prisons
    K Dolan
    National Drug and Alcohol Research Centre, UNSW, Sydney, Australia
    Drug Alcohol Depend 50:197-202. 1998
    ..The estimated minimum (and maximum) number of IDU inmates, infected with HIV in NSW prisons was 38 (and 152) in 1993 according to the model. These figures require confirmation by seroincidence studies...
  17. ncbi request reprint Drug consumption facilities: an update since 2000
    J Kimber
    National Drug and Alcohol Research Center, University of New South Wales, Australia
    Drug Alcohol Rev 22:227-33. 2003
    ..This Digest is a 'must read' for policy makers, advocates and practitioners in the drug field...
  18. ncbi request reprint Survey of drug consumption rooms: service delivery and perceived public health and amenity impact
    Jo Kimber
    National Drug and Alcohol Research Centre, University of New South Wales, and Alcohol and Drug Service, St Vincent s Hospital, Sydney, Australia
    Drug Alcohol Rev 24:21-4. 2005
    ..No overdose deaths were reported and the estimated rate of non-fatal overdose ranged from 1 to 36 per 10,000 visits. These DCRs appeared to be achieving their service delivery objectives with few negative consequences...
  19. ncbi request reprint Decreased heroin availability in Sydney in early 2001
    Carolyn Day
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Addiction 98:93-5. 2003
    ..To examine the veracity of reports of a substantial decrease in the availability of heroin in Sydney in January 2001...
  20. pmc Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C
    G V Matthews
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
    Clin Infect Dis 52:803-11. 2011
    ..The extent to which these separate epidemics overlap is unknown...
  21. ncbi request reprint Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001
    Matthew G Law
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, 376 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
    Int J Epidemiol 32:717-24. 2003
    ....
  22. pmc Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection
    Jason Grebely
    National Centre in HIV Epidemiology and Clinical Research NCHECR, University of New South Wales UNSW, Sydney, Australia
    Hepatology 52:1216-24. 2010
    ..Early therapeutic intervention could be recommended for individuals with unfavorable IL28B genotypes...
  23. pmc Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study
    J Grebely
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 376 Victoria Street, Darlinghurst, Sydney, NSW 2010, Australia
    Drug Alcohol Depend 107:244-9. 2010
    ..Decisions about whether to initiate treatment for recently acquired HCV were mainly driven by clinical factors, rather than factors related to sociodemographics or injecting behaviors...
  24. pmc Effective treatment of injecting drug users with recently acquired hepatitis C virus infection
    Gregory J Dore
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    Gastroenterology 138:123-35.e1-2. 2010
    ..We evaluated the efficacy of treatment of recent HCV infection in IDUs with acute and early chronic HCV...
  25. pmc Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C
    G V Matthews
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    Clin Infect Dis 48:650-8. 2009
    ..Enrollment is open to both human immunodeficiency virus (HIV)-infected and -uninfected individuals. The aim of this article was to evaluate characteristics and virological outcomes among HIV-infected individuals enrolled in ATAHC...
  26. ncbi request reprint Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination?
    Carolyn Day
    National Drug and Alcohol Research Centre, University of New South Wales, Australia
    Drug Alcohol Rev 22:317-21. 2003
    ..In managing IDU patients, health care workers need to be cognizant of the impact that their attitude has on treatment outcome...
  27. ncbi request reprint Modelling the hepatitis C virus epidemic in Australia
    Karina Razali
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW 2010, Australia
    Drug Alcohol Depend 91:228-35. 2007
    ..This paper updates estimates of HCV incidence and prevalence between 1960 and 2005...
  28. doi request reprint An exploratory study of needlestick injuries among Australian prison officers
    Sarah Larney
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    Int J Prison Health 4:164-8. 2008
    ..Needlestick injuries appear to be a relatively rare occurrence, but may be further reduced by improving search techniques and equipment and regulating needles and syringes in prisons...
  29. doi request reprint Injecting drug users' understanding of hepatitis C
    Susannah O'Brien
    National Drug and Alcohol Research Centre, University of New South Wales, NSW 2052, Australia
    Addict Behav 33:1602-5. 2008
    ..Findings warrant further development of, and research into, strategies to improve IDUs' understanding of HCV...
  30. doi request reprint A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?
    Sarah Larney
    Program of International Research and Training, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, N S W, Australia
    Eur Addict Res 15:107-12. 2009
    ..The aim of this paper was to examine the extent to which OST has been implemented in prisons internationally...
  31. ncbi request reprint Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users
    Carolyn Day
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Darlinghurst, New South Wales, Australia
    Aust J Rural Health 14:120-5. 2006
    ....
  32. ncbi request reprint Evaluation of the condom distribution program in New South Wales Prisons, Australia
    Kate Dolan
    National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia
    J Law Med Ethics 32:124-8. 2004
  33. ncbi request reprint Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort
    Jeffrey J Post
    Department of Pathology, School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia
    J Infect Dis 189:1846-55. 2004
    ..These cases highlight the potential for cellular immune responses against HCV to facilitate viral clearance, responses that may model those required for effective HCV vaccination...
  34. pmc Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia
    Jennifer A Gates
    National Drug and Alcohol Research Centre, UNSW, Sydney, 2052, Australia
    J Urban Health 81:448-52. 2004
    ..Prisons are likely to remain an important site for the diagnosis of HCV infection and targeted interventions aimed at risk reduction among inmates with low education levels and a previous imprisonment history...
  35. ncbi request reprint Hepatitis C transmission and HIV post-exposure prophylaxis after needle- and syringe-sharing in Australian prisons
    Belinda G O'Sullivan
    New South Wales Department of Health, Sydney, NSW, Australia
    Med J Aust 178:546-9. 2003
    ....
  36. ncbi request reprint Hair analysis underestimates heroin use in prisoners
    James Shearer
    National Drug and Alcohol Research Centre, UNSW, Sydney, Australia
    Drug Alcohol Rev 25:425-31. 2006
    ..001) between self-reported frequency of heroin use and morphine concentrations in hair. Sectional hair analysis, a reflection of duration of drug use, was uninformative and generally impractical due to the length of hair sections needed...